109 related articles for article (PubMed ID: 35482468)
1. Monitoring Simvastatin Adherence in Patients With Coronary Heart Disease: A Proof-of-Concept Study Based on Pharmacokinetic Measurements in Blood Plasma.
Vethe NT; Husebye E; Andersen AM; Bergan S; Kristiansen O; Fagerland MW; Munkhaugen J
Ther Drug Monit; 2022 Aug; 44(4):558-567. PubMed ID: 35482468
[TBL] [Abstract][Full Text] [Related]
2. A novel direct method to determine adherence to atorvastatin therapy in patients with coronary heart disease.
Kristiansen O; Vethe NT; Fagerland MW; Bergan S; Munkhaugen J; Husebye E
Br J Clin Pharmacol; 2019 Dec; 85(12):2878-2885. PubMed ID: 31495943
[TBL] [Abstract][Full Text] [Related]
3. Dual cholesterol inhibition with ezetimibe/simvastatin in pre-treated hypercholesterolaemic patients with coronary heart disease or diabetes mellitus: prospective observational cohort studies in clinical practice.
Hildemann SK; Barho C; Karmann B; Darius H; Bestehorn K
Curr Med Res Opin; 2007 Apr; 23(4):713-9. PubMed ID: 17407627
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and safety of ezetimibe/simvastatin combination tablet: an open-label, single-dose study in healthy Chinese subjects.
Chu NN; Chen WL; Xu HR; Li XN
Clin Drug Investig; 2012 Dec; 32(12):791-8. PubMed ID: 23109219
[TBL] [Abstract][Full Text] [Related]
5. Safety of low-density lipoprotein cholestrol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE trial).
März W; Wollschläger H; Klein G; Neiss A; Wehling M
Am J Cardiol; 1999 Jul; 84(1):7-13. PubMed ID: 10404843
[TBL] [Abstract][Full Text] [Related]
6. STATT: a titrate-to-goal study of simvastatin in Asian patients with coronary heart disease. Simvastatin Treats Asians to Target.
Chung N; Cho SY; Choi DH; Zhu JR; Lee K; Lee PY; Lee SH; Lee S; Wang JJ; Yin WH; Young MS; Koh KK; Son JW; Sangwatanaroj S; Panchavinnin P; Phankingthongkum R; Cai NS; Fan WF
Clin Ther; 2001 Jun; 23(6):858-70. PubMed ID: 11440286
[TBL] [Abstract][Full Text] [Related]
7. Cost-minimization analysis of simvastatin versus atorvastatin for maintenance therapy in patients with coronary or peripheral vascular disease.
Attanasio E; Russo P; Allen SE
Clin Ther; 2001 Feb; 23(2):276-83; discussion 274-5. PubMed ID: 11293560
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of morning versus evening dose of controlled-release simvastatin tablets in patients with hyperlipidemia: a randomized, double-blind, multicenter phase III trial.
Kim SH; Kim MK; Seo HS; Hyun MS; Han KR; Cho SW; Kim YK; Hoon Park S
Clin Ther; 2013 Sep; 35(9):1350-60.e1. PubMed ID: 23998970
[TBL] [Abstract][Full Text] [Related]
9. Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.
Foody JM; Toth PP; Tomassini JE; Sajjan S; Ramey DR; Neff D; Tershakovec AM; Hu H; Tunceli K
Vasc Health Risk Manag; 2013; 9():719-27. PubMed ID: 24265554
[TBL] [Abstract][Full Text] [Related]
10. A Method for Direct Monitoring of Atorvastatin Adherence in Cardiovascular Disease Prevention: Quantification of the Total Exposure to Parent Drug and Major Metabolites Using 2-Channel Chromatography and Tandem Mass Spectrometry.
Vethe NT; Munkhaugen J; Andersen AM; Husebye E; Bergan S
Ther Drug Monit; 2019 Feb; 41(1):19-28. PubMed ID: 30633723
[TBL] [Abstract][Full Text] [Related]
11. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.
Haffner SM; Alexander CM; Cook TJ; Boccuzzi SJ; Musliner TA; Pedersen TR; Kjekshus J; Pyörälä K
Arch Intern Med; 1999 Dec 13-27; 159(22):2661-7. PubMed ID: 10597756
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
Roeters van Lennep HW; Liem AH; Dunselman PH; Dallinga-Thie GM; Zwinderman AH; Jukema JW
Curr Med Res Opin; 2008 Mar; 24(3):685-94. PubMed ID: 18226326
[TBL] [Abstract][Full Text] [Related]
13. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia.
Matsuzaki M; Kita T; Mabuchi H; Matsuzawa Y; Nakaya N; Oikawa S; Saito Y; Sasaki J; Shimamoto K; Itakura H;
Circ J; 2002 Dec; 66(12):1087-95. PubMed ID: 12499611
[TBL] [Abstract][Full Text] [Related]
14. Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients.
Averna M; Zaninelli A; Le Grazie C; Gensini GF
J Clin Lipidol; 2010; 4(4):272-8. PubMed ID: 21122660
[TBL] [Abstract][Full Text] [Related]
15. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
Heart Protection Study Collaborative Group
Lancet; 2002 Jul; 360(9326):7-22. PubMed ID: 12114036
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S).
Miettinen TA; Pyörälä K; Olsson AG; Musliner TA; Cook TJ; Faergeman O; Berg K; Pedersen T; Kjekshus J
Circulation; 1997 Dec; 96(12):4211-8. PubMed ID: 9416884
[TBL] [Abstract][Full Text] [Related]
17. Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study).
Tikkanen MJ; Holme I; Cater NB; Szarek M; Faergeman O; Kastelein JJ; Olsson AG; Larsen ML; Lindahl C; Pedersen TR;
Am J Cardiol; 2009 Mar; 103(5):577-82. PubMed ID: 19231315
[TBL] [Abstract][Full Text] [Related]
18. Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study.
Rump LC; Baranova E; Okopien B; Weisskopf M; Kandra A; Ferber P
Clin Ther; 2008 Oct; 30(10):1782-93. PubMed ID: 19014834
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy and level of adherence for morning versus evening versus before bedtime administration of simvastatin in hypercholesterolemic patients.
Heng WK; Ng YP; Ooi GS; Habshoh J; Nurazlin J; Nor Azah MN; Hasniza H; Noriza W
Med J Malaysia; 2019 Dec; 74(6):477-482. PubMed ID: 31929472
[TBL] [Abstract][Full Text] [Related]
20. Lack of pharmacokinetic interaction of mipomersen sodium (ISIS 301012), a 2'-O-methoxyethyl modified antisense oligonucleotide targeting apolipoprotein B-100 messenger RNA, with simvastatin and ezetimibe.
Yu RZ; Geary RS; Flaim JD; Riley GC; Tribble DL; vanVliet AA; Wedel MK
Clin Pharmacokinet; 2009; 48(1):39-50. PubMed ID: 19071883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
